Evidence map›Paper›PMID 41476985›Full record

ArticleFrontiers in immunology2025

Temporal modulation of gene expression in a controlled

Dawei Li, Chuan Jiang, Wenyu Zhu, Emma L Houlder, Koen A Stam, Jan Pieter R Koopman, Marijke Langenberg, Ranmali Kavishna, Sara Torkzadeh, Björn Andersson and 14 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Dawei Li *Department of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Chuan Jiang *Department of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Wenyu Zhu *Department of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Emma L HoulderLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Koen A StamLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Jan Pieter R KoopmanLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Marijke LangenbergLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Ranmali KavishnaDepartment of Microbiology & Immunology, Institute of Biomedicine, Gothenburg, Sweden.
Sara TorkzadehDepartment of Microbiology & Immunology, Institute of Biomedicine, Gothenburg, Sweden.
Björn AnderssonDepartment of Microbiology & Immunology, Institute of Biomedicine, Gothenburg, Sweden.
Josefine PerssonDepartment of Microbiology & Immunology, Institute of Biomedicine, Gothenburg, Sweden.
Aravindan KalyanasundaramDepartment of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Mumtaz Y BalkhiDepartment of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Desalegn W KifleDepartment of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Aryandra AryaDepartment of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Hyon Jin JeonInternational Vaccine Institute, Seoul, Republic of Korea.
Birkneh T TadesseInternational Vaccine Institute, Seoul, Republic of Korea.
Sean A GrayPAI Life Sciences Inc., Seattle, WA, United States.
Darrick CarterPAI Life Sciences Inc., Seattle, WA, United States.
Alison M ElliottMedical Research Council, Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.
Ali M HarandiDepartment of Microbiology & Immunology, Institute of Biomedicine, Gothenburg, Sweden.
Meta RoestenbergLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Afzal A SiddiquiDepartment of Immunology & Molecular Microbiology, Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, United States.

Funding

Co-targeting Ezh2 with PD1 to improve T cell exhaustion reversal and tumor responsesR43CA244048 · NCI · IT BIO, LLC · PI YASEEN BALKHI, MUMTAZ · 2019 to 2019
$225k
NCI NIH HHS R43 CA244048
6 · The paper itself

Abstract

Background: Schistosomiasis is caused by parasitic blood flukes of the genus Methods: We conducted a longitudinal transcriptomic study of peripheral blood samples from 30 Results: Robust and highly time-dependent transcriptional responses were observed, peaking at Week 4 post-infection. Differential gene expression and pathway analyses revealed activation of immune responses, including type I and II interferon signaling, chemokine-mediated pathways, and antigen presentation. Notably, both Th1 and Th2 signatures were evident at Week 4. Key immune hubs included Conclusions: This study provides a comprehensive transcriptional map of early host responses to

Indexed as

Gene Expression RegulationSchistosoma mansoniSchistosomiasis mansoniTranscriptomeAdultAnimalsFemaleGene Expression ProfilingHost-Parasite InteractionsHumansMaleYoung Adultcontrolled human infectionparasiteRNA-Seqschistosomiasis (S. mansoni)single-sex

Identifiers

PMID41476985
PMCPMC12748245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.